ZERBATO BARBARA

Zerbato, B., Brancato, V., Gobbi, M., Pessina, A., Brambilla, L., Wegner, A., et al. (2024). Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy. Intervento presentato a: FEBS YSF 2024, Pavia, Italy. Detail

Zerbato, B., Gobbi, M., Ludwig, T., Brancato, V., Pessina, A., Brambilla, L., et al. (2024). PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response. Intervento presentato a: 1st Italian Pancreatic Cancer Symposium (IPCC), Padua, Italy. Detail

Zerbato, B., Brancato, V., Gobbi, M., Pessina, A., Brambilla, L., Wegner, A., et al. (2024). Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy. In Mining biochemistry for human health and well-being, 48th FEBS Congress, 29 June–3 July 2024, Milano, Italy (pp.291-292). WILEY. Detail

Yang, L., Zerbato, B., Pessina, A., Brambilla, L., Andreani, V., Frey-Jakobs, S., et al. (2024). PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect. FRONTIERS IN IMMUNOLOGY, 15 [10.3389/fimmu.2024.1500381]. Detail

Venturi, S., Chiaradonna, F., Gatti, F., La Ferla, B., Parolini, R., Zerbato, B. (2024). Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells. CHEMICAL COMMUNICATIONS, 60(51), 6524-6527 [10.1039/d4cc01220h]. Detail